References

Acetaminophen for prevention and treatment of organ dysfunction in critically ill patients with sepsis: The ASTER randomized clinical trial.

10.1001/jama.2024.8772 · 2024 · External reference

Preexisting diabetes mellitus and all-cause mortality in adult patients with sepsis: A population-based cohort study.

2024 · External reference

Diabetes and sepsis: Preclinical findings and clinical relevance.

10.2337/dc10-1185 · 2011 · External reference

Metabolic messengers: Tumour necrosis factor.

10.1038/s42255-021-00470-z · 2021 · External reference

Inflammation in atherosclerosis.

10.1038/nature01323 · 2002 · External reference

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

10.1681/asn.2011060627 · 2012 · External reference

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

10.1681/asn.2011060628 · 2012 · External reference

Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.

10.1111/j.1399-0039.2009.01332.x · 2009 · External reference

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: A prospective cohort study.

10.1186/s13054-019-2684-2 · 2019 · External reference

Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes – findings from two community based cohorts of elderly.

10.1016/j.atherosclerosis.2014.09.005 · 2014 · External reference

Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: A prospective cohort study.

10.1371/journal.pone.0122073 · 2015 · External reference

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

10.1161/01.cir.93.4.704 · 1996 · External reference

Possible association of tumor necrosis factor receptor 2 gene polymorphism with severe hypertension using the extreme discordant phenotype design.

10.1038/hr.2009.91 · 2009 · External reference

Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

10.2337/diabetes.47.11.1757 · 1998 · External reference

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

10.1002/sim.3697 · 2009 · External reference

Sensitivity analysis in observational research: Introducing the E-value.

10.7326/m16-2607 · 2017 · External reference

Recommendations for presenting analyses of effect modification and interaction.

10.1093/ije/dyr218 · 2012 · External reference

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

10.1172/jci117936 · 1995 · External reference

A metalloproteinase disintegrin that releases tumour necrosis factor-alpha from cells.

10.1038/385729a0 · 1997 · External reference

The shedding protease ADAM17: Physiology and pathophysiology.

10.1016/j.bbamcr.2017.07.001 · 2017 · External reference

Tumor necrosis factor signaling.

10.1038/sj.cdd.4401189 · 2003 · External reference

Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages.

10.1038/ni.2043 · 2011 · External reference

Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production.

10.1189/jlb.70.5.821 · 2001 · External reference

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.

10.4049/jimmunol.151.3.1548 · 1993 · External reference

Identifying molecular phenotypes in sepsis: An analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.

10.1016/s2213-2600(23)00237-0 · 2023 · External reference